iBio, Inc. (IBIO)

NASDAQ: IBIO · Real-Time Price · USD

2.200

-0.010 (-0.45%)

At close: Jan 16, 2026, 4:00 PM EST

2.250

+0.050 (2.27%)

After-hours: Jan 16, 2026, 7:20 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2024	FY 2022	FY 2021	FY 2020	FY 2019	2006 - 2018
Period Ending	Jun '24 Jun 30, 2024	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	2006 - 2018
Precision Antibodies	225.00K	Log In	Log In	Log In	Log In	Upgrade
Biopharmaceuticals (iBio Inc.)	-	Log In	Log In	Log In	Log In	Upgrade
Biopharmaceuticals (iBio Inc.) Growth	-	Log In	Log In	Log In	Log In	Upgrade
Bioprocessing (iBio CDMO)	-	Log In	Log In	Log In	Log In	Upgrade
Bioprocessing (iBio CDMO) Growth	-	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2024	FY 2022	FY 2021	FY 2020	FY 2019	2006 - 2018
Period Ending	Jun '24 Jun 30, 2024	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	2006 - 2018
United States	225.00K	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-90.56%	Log In	Log In	Log In	Log In	Upgrade